AYLA

Noble Financial analyst Robert LeBoyer maintained a Hold rating on Ayala Pharmaceuticals (AYLA - Research Report) on October 7. The company's shares closed yesterday at $0.91.LeBoyer covers the Healthcare sector, focusing on stocks such as Ayala Pharmaceuticals, Axcella Health, and Onconova Therapeutics. According to TipRanks, LeBoyer has an average return of -1.2% and a 22.92% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Ayala Pharmaceuticals with a $12.00 average price target.See today’s best-performing stocks on TipRanks >>The company has a one-year high of $14.50 and a one-year low of $0.70.
https://www.tipranks.com/news/blurbs/noble-financial-reaffirms-their-hold-rating-on-ayala-pharmaceuticals-ayla?utm_source=advfn.com&utm_medium=referral